<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001760460</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001600132</issuerCik>
      <issuerName>Bellerophon Therapeutics, Inc.</issuerName>
      <secFileNumber>001-36845</secFileNumber>
      <issuerAddress>
        <com:street1>184 LIBERTY CORNER ROAD, SUITE 302</com:street1>
        <com:city>WARREN</com:city>
        <com:stateOrCountry>NY</com:stateOrCountry>
        <com:zipCode>07059</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>908-574-4770</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Puissance Life Science Opportunities Fund VI</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>10% Stockholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Commonn Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Goldman Sachs &amp; Co. LLC</name>
        <address>
          <com:street1>200 West Street</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10282</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>134421</noOfUnitsSold>
      <aggregateMarketValue>111380.00</aggregateMarketValue>
      <noOfUnitsOutstanding>1211262</noOfUnitsOutstanding>
      <approxSaleDate>06/07/2023</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>05/21/2020</acquiredDate>
      <natureOfAcquisitionTransaction>Private Placement</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>From the Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>1153846</amountOfSecuritiesAcquired>
      <paymentDate>05/21/2020</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Puissance Life Science Opportunities Fund VI</name>
        <address>
          <com:street1>45 E 85th St</com:street1>
          <com:street2>9E</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10028</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>05/18/2023</saleDate>
      <amountOfSecuritiesSold>560000</amountOfSecuritiesSold>
      <grossProceeds>5297600.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>06/07/2023</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>06/07/2023</planAdoptionDate>
      </planAdoptionDates>
      <signature>Theodore T. Wang</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
